Kenji Egusa

This inventor holds 8 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2015-2023.

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 87.5

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 83(Granted Patents)

Location History:

Ikeda, JP (2020)
Biberach an der Riss, DE (2016 - 2021)
Osaka, JP (2015 - 2023)

Company Filing History:

8 out of 1,560

Boehringer Ingelheim International Gmbh

patents

Years Active: 2015-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11564886 - Pharmaceutical compositions (2023-01-31),

2. 10973827 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2021-04-13),

3. 10603292 - Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof (2020-03-31),

4. 10596120 - Pharmaceutical compositions (2020-03-24),

5. 10022379 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2018-07-17),

6. 9555001 - Pharmaceutical composition and uses thereof (2017-01-31),

7. 9415016 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2016-08-16),

8. 9155705 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation (2015-10-13),

Title: Kenji Egusa - Innovator from Biberach an der Riss

Introduction: Kenji Egusa is a renowned inventor hailing from Biberach an der Riss, Germany. His innovative spirit and dedication to creating groundbreaking solutions have earned him recognition in the field of technology and patents.

Latest Patents: Kenji Egusa holds several patents in the field of biotechnology, particularly focusing on novel drug delivery systems and medical devices. His recent patents showcase his commitment to advancing healthcare through cutting-edge inventions.

Career Highlights: Throughout his career, Kenji Egusa has worked with leading research institutions and pharmaceutical companies to develop innovative solutions for complex medical challenges. His contributions have significantly impacted the healthcare industry, improving patient outcomes and quality of life.

Collaborations: Kenji Egusa has collaborated with top scientists, engineers, and medical professionals to bring his inventions to life. His ability to work across disciplines and industries has led to successful partnerships that have pushed the boundaries of innovation in biotechnology.

Conclusion: Kenji Egusa's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His dedication to improving healthcare through groundbreaking inventions continues to inspire the next generation of innovators.